In Fight Against Lung Cancer Study Offers New Hope

Armen Hareyan's picture
Advertisement

Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small-cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.

Advertisement